Finance

Lists
Why is 524412 up 4,10%?
Dive Deeper
524412:BOM
Aarey Drugs and Pharmaceuticals Ltd
112,90 INR
+4,10%
(+4,45) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524412...
Open
107,55 INR
High
113,50 INR
Low
105,40 INR
Mkt. cap
3,61 მლრდ.
Avg. vol.
12,55 ათ.
Volume
5,29 ათ.
P/E ratio
88,74
52-wk high
113,50 INR
52-wk low
50,40 INR
EPS
1,27 INR
No. of employees
0
Open
107,55 INR
High
113,50 INR
Low
105,40 INR
Mkt. cap
3,61 მლრდ.
Avg. vol.
12,55 ათ.
Volume
5,29 ათ.
P/E ratio
88,74
52-wk high
113,50 INR
52-wk low
50,40 INR
EPS
1,27 INR
No. of employees
0
News stories
From web sources and news partners
About Aarey Drugs and Pharmaceuticals Ltd
CEO-
Employees0
Founded1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
841,62 მლნ.
964,26 მლნ.
1,89 მლრდ.
446,26 მლნ.
Cost of goods sold
804,83 მლნ.
967,96 მლნ.
1,79 მლრდ.
421,54 მლნ.
Cost of revenue
804,83 მლნ.
967,96 მლნ.
1,79 მლრდ.
421,54 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,08 მლნ.
4,25 მლნ.
-3,60 მლნ.
6,89 მლნ.
Operating expense
17,29 მლნ.
19,69 მლნ.
50,37 მლნ.
19,96 მლნ.
Total operating expenses
822,12 მლნ.
987,65 მლნ.
1,85 მლრდ.
441,50 მლნ.
Operating income
19,50 მლნ.
-23,39 მლნ.
49,56 მლნ.
4,75 მლნ.
Other non operating income
7,93 მლნ.
41,82 მლნ.
-72,35 მლნ.
17,15 მლნ.
EBT including unusual items
14,82 მლნ.
9,24 მლნ.
12,80 მლნ.
5,16 მლნ.
EBT excluding unusual items
14,82 მლნ.
9,24 მლნ.
12,80 მლნ.
5,16 მლნ.
Income tax expense
4,58 მლნ.
3,54 მლნ.
2,77 მლნ.
-5,08 მლნ.
Effective tax rate
30,92%
38,35%
21,66%
-98,55%
Other operating expenses
4,29 მლნ.
7,18 მლნ.
45,51 მლნ.
4,57 მლნ.
Net income
10,24 მლნ.
5,70 მლნ.
10,03 მლნ.
10,24 მლნ.
Net profit margin
1,22%
0,59%
0,53%
2,29%
Earnings per share
-
-
-
-
Interest and investment income
-
-
46,30 მლნ.
-
Interest expense
-12,60 მლნ.
-9,19 მლნ.
-10,76 მლნ.
-16,74 მლნ.
Net interest expenses
-12,60 მლნ.
-9,19 მლნ.
35,54 მლნ.
-16,74 მლნ.
Depreciation and amortization charges
6,93 მლნ.
8,26 მლნ.
8,46 მლნ.
8,50 მლნ.
EBITDA
25,40 მლნ.
-18,53 მლნ.
56,69 მლნ.
11,88 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები